GlassScriptPhysician profile
Vineeta A Estes
NPI 1477597102
$2,455.60
in general payments reported to CMS, 2019-2025
30 companies · $416 in 2025
The $416 reported for 2025 was more than what 76% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $214 · 2020: $673 · 2021: $575 · 2022: $111 · 2023: $58.98 · 2024: $409 · 2025: $416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $883.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $883.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biom'Up France Sas | $1,003.05 | 2020-2021 | |
| Abbvie INC. | $148.17 | 2019-2024 | |
| Ethicon US, LLC | $135.09 | 2025 | Dermabond Prineo, Vistaseal, Surgiflo Hemostatic Matrix |
| Biom'Up Sa | $124.14 | 2019 | |
| Intuitive Surgical, INC. | $110.10 | 2024 | |
| Sumitomo Pharma America, INC. | $108.77 | 2024-2025 | Gemtesa, Myfembree |
| Organon LLC | $107.52 | 2021-2025 | Nexplanon, Jada System |
| Baxter Healthcare | $86.00 | 2024 | Perclot |
| Allergan, INC. | $57.67 | 2020-2021 | |
| Sage Therapeutics, LLC | $57.04 | 2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $52.21 | 2019-2023 | |
| Applied Medical Resources Corporation | $49.88 | 2022 | |
| Hologic Sales and Service, LLC | $48.06 | 2024-2025 | Aptima, Fluent Fluid Management System, Novasure |
| Astellas Pharma US INC | $44.59 | 2025 | Veozah |
| Shield Therapeutics INC | $33.40 | 2024 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $31.12 | 2021 | |
| Mayne Pharma Commercial LLC | $28.43 | 2025 | |
| Tempus Ai, INC | $26.36 | 2024 | |
| Asensus Surgical, INC. | $26.12 | 2020 | |
| Exeltis, USA INC. | $21.13 | 2025 | Slynd |
| Alydia Health | $20.95 | 2021 | |
| Supernus Pharmaceuticals, INC. | $20.20 | 2025 | Qelbree |
| Agile Therapeutics, INC. | $18.26 | 2021 | |
| Evofem Biosciences, INC. | $16.44 | 2022 | |
| Boston Scientific Corporation | $15.54 | 2019 | |
| Myovant Sciences INC. | $14.10 | 2022 | |
| Coopersurgical, INC. | $13.81 | 2023 | Vaginal Speculum - Snowman/ Pederson Blade |
| Minerva Surgical, INC | $13.65 | 2019 | |
| Lupin INC. | $12.13 | 2019 | |
| Daiichi Sankyo INC. | $11.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vineeta Estes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.